Orange, CA10 Active Studies

Non-Small Cell Lung Cancer Clinical Trials in Orange, CA

Find 10 actively recruiting non-small cell lung cancer clinical trials in Orange, CA. Connect with local research sites and explore new treatment options.

10
Active Trials
9
Sponsors
4,141
Enrolling

Recruiting Non-Small Cell Lung Cancer Studies in Orange

About Non-Small Cell Lung Cancer Clinical Trials in Orange

Non-small cell lung cancer (NSCLC) accounts for about 85% of all lung cancers. Subtypes include adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Treatment has been transformed by targeted therapies and immunotherapy based on specific genetic markers.

There are currently 10 non-small cell lung cancer clinical trials recruiting participants in Orange, CA. These studies are seeking a combined 4,141 participants. Research is being sponsored by Nuvalent Inc., Revolution Medicines, Inc., Janssen Research & Development, LLC and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Non-Small Cell Lung Cancer Clinical Trials in Orange — FAQ

Are there non-small cell lung cancer clinical trials in Orange?

Yes, there are 10 non-small cell lung cancer clinical trials currently recruiting in Orange, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Orange?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Orange research site will contact you about next steps.

Are clinical trials in Orange free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Orange studies also compensate for your time and travel.

What non-small cell lung cancer treatments are being tested?

The 10 active trials in Orange are testing new therapies including novel drugs, biologics, and treatment approaches for non-small cell lung cancer.

Data updated October 17, 2026 from ClinicalTrials.gov